# US 2021/0278394 A1 · Anastasis biosensor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0278394 A1
- Document ID: US20210278394A1
- Status: Published application
- Kind: A1
- Application number: 16/461,398
- Filed: 2017-11-16
- Published: 2021-09-09
- Earliest claimed: 2016-11-16
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Ho Lam Tang; Ho Man Holly Tang
- Web page: https://patentgrep.com/patent/US20210278394A1

## CPC

- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- C12N 9/96: Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
- C07K 2319/03: containing a transmembrane segment
- C07K 2319/50: containing protease site
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- G01N 2510/00: Detection of programmed cell death, i.e. apoptosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to the field of anastasis, i.e., the process of reversal of apoptosis. More specifically, the present invention provides methods and compositions useful for studying anastasis. The present invention also provides a biosensor comprising (a) a split transcription factor complex comprising one half of a split transcription factor linked to a transmembrane domain via an enzyme cleavable linker; (b) a split transcription factor comprising the other half of the split transcription factor linked to a MTS via an enzyme-cleavable linker; and (c) a reporter system comprising (1) a first nucleic acid encoding a site specific recombinase operably linked to the site specific sequence for the transcription factor; and (2) a second nucleic acid comprising a stop codon cassette flanked by site specific recombination sequences, wherein the split transcription factor is Gal 4 or split Q. In other embodiments, the recombinase is Cre or FLP.

## Claims

### Claim 1

An anastasis biosensor comprising:
(a) a first transcription factor complex comprising either the N-terminal or C-terminal fragment of the Gal4 transcription factor linked to a transmembrane domain via an enzyme cleavable linker;
(b) a second transcription factor complex comprising either the N-terminal or C-terminal fragment of the Gal4 transcription factor linked to a mitochondrial targeting sequence (MTS) via an enzyme cleavable linker, wherein the N-terminal fragment of the Gal4 transcription factor is used if the first transcription factor complex of element (a) comprises the C-terminal fragment of the Gal4 transcription factor or wherein the C-terminal fragment of the Gal4 transcription factor is used if the first transcription factor complex of element (a) comprises the N-terminal fragment of the Gal4 transcription factor; and
(c) a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.

### Claim 2 (depends on 1)

The anastasis biosensor of claim 1, wherein the enzyme cleavable linker of element (a) is cleaved by an enzyme specifically expressed during apoptosis.

### Claim 3 (depends on 1)

The anastasis biosensor of claim 1, wherein the enzyme of element (a) is a caspase.

### Claim 4 (depends on 1)

The anastasis biosensor of claim 1, wherein the enzyme of element (b) is an inner membrane protease (IMP).

### Claim 5 (depends on 1)

The anastasis biosensor of claim 1, wherein the fluorescent protein comprises green fluorescent protein, red fluorescent protein, or yellow fluorescent protein.

### Claim 6 (depends on 1)

A transgenic mammal comprising the biosensor of claim 1.

### Claim 7

A biosensor for studying anastasis comprising:
(a) a caspase-activatable transcription factor complex comprising either the N-terminal or C-terminal fragment of the split Gal4 transcription factor that is linked to a transmembrane domain via a caspase-cleavable linker;
(b) an IMP-activatable transcription factor complex comprising either the N-terminal or C-terminal fragment of the split Gal4 transcription factor linked to a MTS via a caspase-cleavable linker; and
(c) a reporter system comprising a (1) first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; (2) a second nucleic acid comprising an FRT-flanked stop cassette separating a constitutive promoter and a fluorescent protein open reading frame.

### Claim 8 (depends on 7)

The biosensor of claim 7, wherein the caspase-cleavable linker comprises the amino acid sequence DEVD (SEQ ID NO:1).

### Claim 9 (depends on 7)

The biosensor of claim 7, wherein the IMP-cleavable linker comprises the amino acid sequence CAVP (SEQ ID NO:2).

### Claim 10 (depends on 7)

The biosensor of claim 7, wherein the constitutive promoter is the ubiquitin promoter.

### Claim 11

A biosensor comprising:
(a) a caspase-activatable transcription factor complex comprising either the N-terminal or C-terminal fragment of the split Gal4 transcription factor linked to a transmembrane domain via a caspase-cleavable linker;
(b) an IMP-activatable transcription factor complex comprising either the N-terminal or C-terminal fragment of the split Gal4 transcription factor linked to a MTS via an IMP-cleavable linker; and
(c) the G-TRACE reporter system.

### Claim 12

A biosensor system comprising:
(a) a caspase-activatable recombinase complex comprising one half of the split Cre recombinase protein linked to a transmembrane domain via a caspase-cleavable linker;
(b) an IMP-activatable recombinase complex comprising the other half of the split Cre recombinase protein linked to a MTS via an IMP-cleavable linkers; and
(c) a nucleic acid comprising a LoxP-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.

### Claim 13

A biosensor system comprising:
(a) a split site-specific recombinase tethered to the plasma membrane of a test cell, wherein the split recombinase is linked to a transmembrane domain via an enzyme cleavable linker;
(b) a split site-specific recombinase comprising the other half of the split recombinase of element (a) expressed in the mitochondria of the test cell, wherein the split recombinase is linked to a MTS via an enzyme cleavable linker; and
(c) a nucleic acid encoding a reporter gene operably linked to a promoter, wherein the recognition target sequence of the recombinase flanks a stop codon cassette located between the reporter gene and the promoter.

### Claim 14 (depends on 13)

The biosensor system of claim 13, wherein the site-specific recombinase is flippase and the recognition target sequence is FRT.

### Claim 15 (depends on 13)

The biosensor system of claim 13, wherein the reporter gene encodes a fluorescent protein.

### Claim 16 (depends on 13)

The biosensor system of claim 13, wherein the promoter is a constitutive promoter.

### Claim 17 (depends on 13)

The biosensor system of claim 13, wherein the enzyme of element (a) is caspase.

### Claim 18 (depends on 13)

The biosensor system of claim 13, wherein the enzyme of element (b) is IMP.

### Claim 19

A biosensor comprising:
(a) a split transcription factor complex comprising one half of a split transcription factor linked to a transmembrane domain via an enzyme cleavable linker; and
(b) a split transcription factor comprising the other half of the split transcription factor linked to a MTS via an enzyme-cleavable linker; and
(c) a reporter system comprising (1) a first nucleic acid encoding a site specific recombinase operably linked to the site specific sequence for the transcription factor; and (2) a second nucleic acid comprising a stop codon cassette flanked by site specific recombination sequences, wherein the stop codon cassette and flanking sequences separate a constitutive promoter and a fluorescent protein open reading frame.

### Claim 20 (depends on 19)

The biosensor of claim 19, wherein the enzyme cleavable linker of element (a) is cleaved by an enzyme specifically expressed during apoptosis.

### Claim 21 (depends on 20)

The biosensor of claim 20, wherein the enzyme is caspase.

### Claim 22 (depends on 19)

The biosensor of claim 19, wherein the enzyme of element (b) is an inner membrane protease (IMP).

### Claim 23 (depends on 19)

The biosensor of claim 19, wherein the split transcription factor is Gal 4 or split Q.

### Claim 24 (depends on 19)

The biosensor of claim 19, wherein the recombinase is Cre or FLP.

### Claim 25 (depends on 19)

The biosensor of claim 19, wherein the fluorescent protein comprises green fluorescent protein, red fluorescent protein, or yellow fluorescent protein.
